Abstract
Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder and the most common inherited cause of hyperammonemia. Clinical manifestations are more severe in hemizygous males who often present in neonatal period. Heterozygous females may be asymptomatic until juvenile or adulthood/Fluctuating concentration of ammonia, glutamine and other excitotoxic amino acids result in a chronic or episodically recurring encephalopathy. The authors report a heterozygous female with OTC deficiency who presented with recurrent encephalopathy
This is a preview of subscription content, log in via an institution to check access.
References
Pridmore CL, Clarke JT, Blaser S. Ornithine transcarbamylase defidency in females: an often overlooked cause of treatable encephalopathy.J Child Neurol 1995; 10 (5): 369–374.
Rowe PC, Newman SL, Brusilow SW. Natural history of symptomatic partial ornithine transcarbamylase deficiency.N Eng J Med 1986; 314:541–547.
Schwartz S, Schwab S, Hoffman GF. Enzyme detects of the urea cycle in differential acute encephalopathy diagnosis in adulthood, diagnosis and current therapy concepts.Nervenarzt 1999; 70 (2): 111–118.
Oechsner M, Steon C, Sturenburg HJ, Huhlschutter A. Hyperammonemic encephalopathy after initiation of valproate therapy in unrecognized ornithine transcarbamylase deficiency.J Neurol Neurosurg Psychiatr 1998; 64 (5): 680–682.
Maestri ME, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis.J Pediatr 1990; 134 (3) : 268–272.
Summar M. Current strategies for the management of neonatal urea cycle disorder.J Pediatr 2001; 138: S31–39.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gulati, S., Menon, S., Kabra, M. et al. Intermittent hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency. Indian J Pediatr 71, 645–647 (2004). https://doi.org/10.1007/BF02724127
Issue Date:
DOI: https://doi.org/10.1007/BF02724127